Doubling time of carcinoembryonic antigen is a significant prognostic factor after the surgical resection of locally recurrent rectal cancer

Digestive Surgery

Volumn 25, Issue 4, 2008, Pages 319-324

  Tanaka, Koji ^a   Noura, Shingo ^a   Ohue, Masayuki ^a   Seki, Yosuke ^a   Yamada, Terumasa ^a   Miyashiro, Isao ^a   Ohigashi, Hiroaki ^a   Yano, Masahiko ^a   Ishikawa, Osamu ^a   Murata, Kohei ^b   Kameyama, Masao ^c   Imaoka, Shingi ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b Suita Municipal Hospital   (Japan)

^c Bell Land General Hospital   (Japan)

Author keywords

Carcinoembryonic antigen; Doubling time; Local recurrence; Rectal cancer

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ARTICLE; CANCER LOCALIZATION; CANCER SURGERY; DIAGNOSTIC ACCURACY; DISTANT METASTASIS; HUMAN; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; RECTUM CANCER; RECURRENT CANCER; SEX DIFFERENCE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 52349100722     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000158597     Document Type: Article

References (38)

1. McDermott FT, Hughes ES, Pihl E, Johnson WR, Price AB: Local recurrence after potentially curative resection for rectal cancer in a series of 1,008 patients. Br J Surg 1985;72:34-37.
2. Bozzetti F, Bertario L, Rossetti C, Gennari L, Andreola S, Baratti D, Gronchi A: Surgical treatment of locally recurrent rectal carcinoma. Dis Colon Rectum 1997;40:1421-1424.
3. Shoup M, Guillem JG, Alektiar KM, Liau K, Paty PB, Cohen AM, Wong WD, Minsky BD: Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy. Dis Colon Rectum 2002;45:585-592.
4. Abulafi AM, Williams NS: Local recurrence of colorectal cancer: The problem, mechanisms, management and adjuvant therapy. Br J Surg 1994;81:7-19.
5. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-646.
6. Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, Rutten H, Pahlman L, Glimelius B, Leer JW, van de Velde CJ: The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007;246:693-701.
7. Mawdsley S, Glynne-Jones R, Grainger J, Richman P, Makris A, Harrison M, Ashford R, Harrison RA, Osborne M, Livingstone JI, MacDonald P, Mitchell IC, Meyrick-Thomas J, Northover JM, Windsor A, Novell R, Wallace M: Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival? Int J Radiat Oncol Biol Phys 2005;63:745-752.
8. Welch JP, Donaldson GA: Detection and treatment of recurrent cancer of the colon and rectum. Am J Surg 1978;135:505-511.
9. Bowne WB, Lee B, Wong WD, Ben-Porat L, Shia J, Cohen AM, Enker WE, Guillem JG, Paty PB, Weiser MR: Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases. Dis Colon Rectum 2005;48:897-909.
10. Frykholm GJ, Pahlman L, Glimelius B: Treatment of local recurrences of rectal carcinoma. Radiother Oncol 1995;34:185-194.
11. Lopez-Kostner F, Fazio VW, Vignali A, Rybicki LA, Lavery IC: Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum 2001;44:173-178.
12. Wiig JN, Tveit KM, Poulsen JP, Olsen DR, Giercksky KE: Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiother Oncol 2002;62:207-213.
13. Christoforidis E, Kanellos I, Tsachalis T, Blouhos K, Lamprou I, Betsis D: Locally recurrent rectal cancer after curative resection. Tech Coloproctol 2004;8(suppl 1):s132-s134.
14. Wong R, Thomas G, Cummings B, Froud P, Shelley W, Withers R, Williams J: In search of a dose-response relationship with radiotherapy in the management of recurrent rectal carcinoma in the pelvis: a systematic review. Int J Radiat Oncol Biol Phys 1998;40:437-446.
15. Suzuki K, Dozois RR, Devine RM, Nelson H, Weaver AL, Gunderson LL, Ilstrup DM: Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum 1996;39:730-736.
16. Rodel C, Grabenbauer GG, Matzel KE, Schick C, Fietkau R, Papadopoulos T, Martus P, Hohenberger W, Sauer R: Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer. Dis Colon Rectum 2000;43:312-319.
17. Gagliardi G, Hawley PR, Hershman MJ, Arnott SJ: Prognostic factors in surgery for local recurrence of rectal cancer. Br J Surg 1995;82:1401-1405.
18. Delpero JR, Pol B, Le Treut P, Bardou VJ, Moutardier V, Hardwigsen J, Granger F, Houvenaeghel G: Surgical resection of locally recurrent colorectal adenocarcinoma. Br J Surg 1998;85:372-376.
19. Collins VP, Loeffler RK, Tivey H: Observations on growth rates of human tumors. Am J Roentgenol Radium Ther Nucl Med 1956;76:988-1000.
20. Tanaka K, Shimada H, Miura M, Fujii Y, Yamaguchi S, Endo I, Sekido H, Togo S, Ike H: Metastatic tumor doubling time: most important prehepatectomy predictor of survival and nonrecurrence of hepatic colorectal cancer metastasis. World J Surg 2004;28:263-270.
21. Staab HJ, Anderer FA, Hornung A, Stumpf E, Fischer R: Doubling time of circulating cea and its relation to survival of patients with recurrent colorectal cancer. Br J Cancer 1982;46:773-781.
22. Koga H, Moriya Y, Akasu T, Fujita S: The relationship between prognosis and CEA-dt after hepatic resection in patients with colorectal carcinomas. Eur J Surg Oncol 1999;25:292-296.
23. Ike H, Shimada H, Ohki S, Yamaguchi S, Ichikawa Y, Fujii S: Outcome of total pelvic exenteration for locally recurrent rectal cancer. Hepatogastroenterology 2003;50:700-703.
24. Wanebo HJ, Koness RJ, Vezeridis MP, Cohen SI, Wrobleski DE: Pelvic resection of recurrent rectal cancer. Ann Surg 1994;220:586-595;discussion 595-597.
25. Wiig JN, Dueland S, Larsen S, Giercksky KE: Treatment of locally recurrent rectal cancer. Tidsskr Nor Laegeforen 2007;127:3097-3101.
26. Asoglu O, Karanlik H, Muslumanoglu M, Igci A, Emek E, Ozmen V, Kecer M, Parlak M, Kapran Y: Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Eur J Surg Oncol 2007;33:1199-1206.
27. Wanebo HJ, Antoniuk P, Koness RJ, Levy A, Vezeridis M, Cohen SI, Wrobleski DE: Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. Dis Colon Rectum 1999;42:1438-1448.
28. Hahnloser D, Nelson H, Gunderson LL, Hassan I, Haddock MG, O'Connell MJ, Cha S, Sargent DJ, Horgan A: Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 2003;237:502-508.
29. Reerink O, Mulder NH, Botke G, Sluiter WJ, Szabo BG, Plukker JT, Verschueren RC, Hospers GA: Treatment of locally recurrent rectal cancer, results and prognostic factors. Eur J Surg Oncol 2004;30:954-958.
30. Salo JC, Paty PB, Guillem J, Minsky BD, Harrison LB, Cohen AM: Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience. Ann Surg Oncol 1999;6:171-177.
31. Onodera H, Maetani S, Kawamoto K, Kan S, Kondo S, Imamura M: Pathologic significance of tumor progression in locally recurrent rectal cancer: different nature from primary cancer. Dis Colon Rectum 2000;43:775-781.
32. Cunningham JD, Enker W, Cohen A: Salvage therapy for pelvic recurrence following curative rectal cancer resection. Dis Colon Rectum 1997;40:393-400.
33. Hashiguchi Y, Sekine T, Sakamoto H, Tanaka Y, Kazumoto T, Kato S, Sakura M, Fuse Y, Suda Y: Intraoperative irradiation after surgery for locally recurrent rectal cancer. Dis Colon Rectum 1999;42:886-893;discussion 893-895.
34. Garcia-Aguilar J, Cromwell JW, Marra C, Lee SH, Madoff RD, Rothenberger DA: Treatment of locally recurrent rectal cancer. Dis Colon Rectum 2001;44:1743-1748.
35. Vermaas M, Ferenschild FT, Nuyttens JJ, Marinelli AW, Wiggers T, van der Sijp JR, Verhoef C, Graveland WJ, Eggermont AM, de Wilt JH: Preoperative radiotherapy improves outcome in recurrent rectal cancer. Dis Colon Rectum 2005;48:918-928.
36. Kuehne J, Kleisli T, Biernacki P, Girvigian M, Streeter O, Corman ML, Ortega AE, Vukasin P, Essani R, Beart RW: Use of high-doserate brachytherapy in the management of locally recurrent rectal cancer. Dis Colon Rectum 2003;46:895-899.
37. Noura S, Ohue M, Murata K, Kameyama M, Kishi K, Takachi K, Eguchi H, Yamada T, Miyashiro I, Yano M, Ohigashi H, Sasaki Y, Ishikawa O, Imaoka S: A case of high-dose rate interstitial brachytherapy for locally recurrent rectal cancer. Gan To Kagaku Ryoho 2006;33:1801-1803.
38. Tsujii H, Mizoe J, Kamada T, Baba M, Tsuji H, Kato H, Kato S, Yamada S, Yasuda S, Ohno T, Yanagi T, Imai R, Kagei K, Kato H, Hara R, Hasegawa A, Nakajima M, Sugane N, Tamaki N, Takagi R, Kandatsu S, Yoshikawa K, Kishimoto R, Miyamoto T: Clinical results of carbon ion radiotherapy at NIRS. J Radiat Res (Tokyo) 2007;48(suppl A):A1-A13.